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Abstract: This study aims to describe current trends in Australia regarding chronic obstructive 
pulmonary disease (COPD) mortality and morbidity rates, and in its treatment and prevention 
from 2000 to 2010. The study’s purpose is to better define future directions in curbing COPD. 
People with COPD and their caregivers who attend patient support groups (n = 21), pulmonary 
rehabilitation group coordinators (n = 27) within Victoria, and the Australian Lung Foundation 
provided informed feedback. COPD was a leading underlying cause of death in both sexes dur-
ing these years. Nevertheless, mortality rates declined from 1980 to 2007, with rates for males 
almost halving. Its prevalence has also substantially declined. Smoking rates have declined in age 
groups over 40 years old in both sexes. The COPD-X Plan provides evidence-based guidelines 
for the management of COPD. Many government, professional, and community initiatives have 
been recently implemented to promote the Plan. Two studies—one conducted before and one 
conducted after the publication of the COPD-X Plan—report some progress, but there are still 
very considerable departures from evidence-based practice. The Australian Lung Foundation 
estimates that only 1% of patients who could benefit from pulmonary rehabilitation programs have 
suitable access to such programs. A common priority for all informants was that there needed to 
be greater awareness of—and a more positive orientation to—COPD in both the Australian and 
health professional communities. The study concluded that substantial reductions in COPD and 
smoking cessation rates contrast with more limited progress toward adopting other aspects of 
evidence-based practice. The “good news” story concerning reductions in COPD disease with 
improving smoking cessation rates could form the basis for suitable media campaigns.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a chronic progressive disease that, 
from the patient’s point of view, is most unpleasant. Assessed by any measure, such as 
mortality, morbidity, disability, overall burden of disease, or health care costs, it is a 
significant cause of poor community health. It is predicted to become the third-leading 
cause of death by 2020 worldwide.1 Nevertheless, it is underdiagnosed and awareness 
of its impact is low. There has been much activity by governments and health care 
professionals, through their contribution to the Global Initiative for Chronic Obstruc-
tive Lung Disease (GOLD), to improve this situation.2 This includes the development 
of evidence-based guidelines that demonstrate that prevention and treatment for the 
disease can be effective. Nevertheless, nihilism about the condition and its treatment 
is widespread.3
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This article consists of two parts. Part A examines some 
recently published research on COPD in Australia concerning 
current levels, risk factors, and the nature of COPD manage-
ment in Australia. Part B reports informants’ perspectives 
about COPD in Australia, particularly in relation to programs 
needed to improve community and professional interest 
in and attitudes toward the disease, as well as to improve 
service delivery.
The aim of assembling these different pieces of evidence 
is to provide a snapshot of the disease in Australia over the 
last decade (2000–2010) and, where possible, to examine 
current trends in COPD mortality and morbidity, as well as 
its prevention and treatment. The purpose of such action is to 
elucidate to what extent there has been progress or otherwise 
in the reduction of COPD levels as a result of improvements 
in services and programs in one medium-size developed 
country. We interpret these findings and their significance in 
pointing to future directions that will best curb COPD.
Part A: Recently published research 
relevant to COPD in Australia
Mortality, morbidity, and burden  
of disease of COPD in Australia
COPD is a significant cause of death in Australia, being 
recorded in 2007 as the underlying cause of 5152 deaths 
(4% of all deaths) and an associated cause in another 7336 
deaths.4 The mortality rate (underlying cause) is 31 per 
100,000 for males and 16 per 100,000 for females. Based 
on these rates, COPD was the fourth-leading underlying 
cause of death for males and sixth for females in Australia in 
2007.5 COPD is also a significant contributor (3.0%) to the 
total burden of disease and injury, a number equally shared 
by males and females.
The 2003 Survey of Disability, Ageing and Carers esti-
mated that approximately 34% of those reporting emphysema 
and bronchitis (as described) have some degree of disability, 
with 12% having severe or profound disability.6 Disability 
was twice as common in males as in females. The estimated 
direct expenditure associated with COPD for 2004–2005 was 
A$548.7 million, 61% of which was for hospitalizations.4 
In 2007–2008, there were 59,427 hospitalizations (1% of 
all hospitalizations) for COPD as the principal diagnosis 
in Australia. The average length of stay (6.9 days) was over 
twice the average of all hospital stays (3.3 days).
Based on self-reported information in the 2007–
2008 National Health Survey, an estimated 490,000 
Australians (2.3% of the population) had emphysema 
or bronchitis (as described).7 This is likely to be an 
underestimate, as people may not be aware they have COPD, 
particularly if they have the mild Stage 1 disease, or if they 
erroneously believe they have asthma.
In general, estimates of COPD prevalence differ according 
to the estimation method used, such as self-reporting and 
doctor diagnoses with or without spirometry. In an epidemio-
logical survey, taken in 2000, that included lung function test-
ing of adults aged 45–70 years from southeastern Melbourne, 
Matheson et al estimated that 3.5% of this population had 
Stage 2 or higher COPD based on the GOLD staging criteria, 
with an extra 3.6% of subjects having COPD (Stage 2 or 3) 
plus asthma.8 Only 10% to 15% of subjects with COPD and 
no other disease had been diagnosed with COPD.
In the Burden of Obstructive Lung Diseases (BOLD) 
international study of COPD prevalence, the prevalence 
of Stage 2 or higher COPD in adults 40 years and over in 
southeastern Sydney was reported as being 10.8%.9 This is 
slightly higher than the 10.1% across the study’s 12 interna-
tional sites. This obscures the fact that prevalence in males 
was in the top quartile, but prevalence in females was in the 
bottom quartile. An unpublished 2011 study by Toelle of 
COPD prevalence in BOLD sites across Australia confirmed 
this Melbourne–Sydney difference.9,10
One estimate of the number of cases of COPD in 
Australia, using both the National Health Survey and BOLD 
studies, was two million across all stages, and 1.2 million 
for Stage 2–4 COPD.11
In Victoria, hospital admission rates for COPD cases 
have remained significantly higher in rural areas compared 
to metropolitan areas.12 Multiple logistic regression analyses 
in this study also revealed that increasing hospital admission 
rates were associated with increased smoking rates within the 
area, as well as its remoteness and social disadvantages.
Recent trends in mortality  
and morbidity in Australia
Figure 1 shows that COPD mortality rates (underlying 
cause) halved from 1980 to 2007.4 Rate changes in males 
and females were very different: rates for males have 
almost halved, while rates for females have risen slightly. 
Despite this, from 1987 to 2006, Australia’s COPD mortality 
ranking has fallen from the top to the middle-third band of 
participating Organization for Economic Cooperation and 
Development (OECD) countries.4
Based on successive national health surveys, the 
prevalence of emphysema and bronchitis (as described) 
declined from 4.1% in 1995 to 2.3% in 2007–2008. 
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COPD hospitalization rates have remained fairly stable from 
1998–1999 to 2006–2007; male rates have declined some-
what, and female rates have increased slightly.13
Trends in tobacco smoking rates  
in Australia
These trends for COPD are better understood in the light 
of smoking rate trends. Smoking rates have declined in 
the age groups over 40 years old in Australia from 1980 to 
2004 (Figure 2).14 Rates in the 60 years and over age group 
have declined from 23% to 13% for males and from 16% 
to 9% for females. In the 40–59 years old age group, rates 
declined from 44% to 24% for males and from 27% to 22% 
for females. Australia’s ranking for smoking rates rose from 
the middle-third to the best-third band of OECD countries 
for the period 1987–2006.4 This decline is consistent with 
the objectives of Australia’s National Tobacco Strategy, 
which aim to prevent the uptake of smoking across all social 
groups, to encourage and assist as many smokers as possible 
in quitting as soon as possible, to eliminate harmful exposure 
to tobacco smoke among nonsmokers and, where feasible, 
to reduce harm associated with the continuing use of and 
dependence on tobacco and nicotine.15
Evidence-based guidelines for the 
management of COPD in Australia
The 2001 GOLD workshop report constituted the original 
primary evidence base that led to the development of the 
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submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
359
Signs of progress in the Australian post-2000 COPD experienceInternational Journal of COPD 2012:7
Australian and New Zealand guidelines for the management 
of COPD (the COPD-X Plan).16 This was a joint initiative of 
the Thoracic Society of Australia and New Zealand and the 
Australian Lung Foundation (ALF), and was first published 
in 2003. Subsequent modifications to the guidelines have 
been based on subsequent versions of the GOLD report 
and on the results of systematic reviews or well-conducted, 
randomized control trials.17
The COPD-X Plan 2010 is summarized in Table 1. 
Guidelines with very direct applications on patient care 
involve pulmonary rehabilitation (PR), treatment of nico-
tine dependence, and influenza vaccination. There are new 
insights in relation to pharmacological treatments and psy-
chosocial supports.
government and nongovernment 
activities to improve COPD management
A  whole  range  of  government,  professional,  and 
community initiatives have been put in place during the 
past 10–15 years to promote the take-up of evidence-based 
management for COPD, the most important of which are 
described below.
First, chronic disease strategies, which prominently 
include COPD, exist at both the Commonwealth and State 
levels.18 The most important include:
•	 Funding for governmental programs of self-management 
and care coordination, such as the Chronic Disease 
Framework (the Australian Better Health Initiative and 
the Australian Primary Care Collaboratives Program)19 
and
•	 Special funding arrangements (the Chronic Disease 
Management [CDM] Medicare Items and Spirometry 
Items) under Medicare Australia, the universal health 
insurance scheme that reimburses patients for medical 
costs.20
Moreover, active smoking quitlines exist in all States and 
Territories (such as Quit Victoria).21
ALF is active in supporting people with COPD. It has 
established, among other initiatives, a National Patient Sup-
port Group Network and a Lung Foundation website, staged 
a National Summit Conference to determine future research 
directions, and set up multidisciplinary consultative groups 
in major lung disease categories that include COPD. It pub-
lishes and promotes the COPD-X guidelines (see above), 
and lists on its Website approximately 160 PR programs for 
COPD and 120 patient support groups for people with lung 
conditions across the country.
Table 1 COPD-X guidelines 2010
C: confirm diagnosis and assess severity
•    Smoking is the most important risk factor in the development  
of COPD
•  Consider COPD in all smokers and exsmokers over the age of 35 years
•    The A diagnosis of COPD rests on the demonstration of airflow 
limitation that is not fully reversible
•    If airflow limitation is fully or substantially reversible (FEV1 response to 
bronchodilator . 400 mL), the patient should be treated as for asthma
•  Consider COPD in patients with other smoking-related diseases
O: optimize function
•    Inhaled bronchodilators provide symptom relief and may increase 
exercise capacity
•  Long-term use of systemic glucocorticoids is not recommended
•    Inhaled glucocorticoids should be considered in patients with 
moderate to severe COPD and frequent exacerbations
•    Pulmonary rehabilitation reduces dyspnea, fatigue, anxiety, and 
depression; improves exercise capacity, emotional function, and 
health-related quality of life; and enhances patients’ sense of control 
over their condition
•    Pulmonary rehabilitation reduces hospitalization and has been shown 
to be cost-effective
•  Prevent or treat osteoporosis
•  Identify and treat hypoxemia and pulmonary hypertension
•    In selected patients, a surgical approach may be considered for 
symptom relief
P: prevent deterioration
•  Smoking cessation reduces the rate of lung function decline
•    Treatment of nicotine dependence is effective and should be offered 
to smokers in addition to counseling
•    Influenza vaccination reduces the risk of exacerbations, hospitalization, 
and death
•  Mucolytics may reduce the frequency and duration of exacerbations
•    Long-term oxygen therapy (.15 hours/day) prolongs life in 
hypoxemic patients (PaO2 , 55 mmHg or 7.3 kPa)
D: develop support networks and self-management
•  COPD imposes handicaps that affect both patients and carers
•  Enhancing quality of life and reducing handicap requires a support team
•    Patients and their family/friends should be actively involved in a 
therapeutic partnership with a range of health professionals
•    Multidisciplinary care plans and individual self-management plans may 
help to prevent or manage crises
•    Patients who take appropriate responsibility for their own 
management may have improved outcomes
•    Anxious and depressive symptoms and disorders are common  
co-morbidities in people with COPD
X: manage eXacerbations
•    An exacerbation is an event in the natural course of the disease 
characterized by a change in the patient’s baseline dyspnea, cough, 
and/or sputum that is beyond normal day-to-day variations, is acute in 
onset, and may warrant a change in regular medication  
in a patient with underlying COPD
•  Early diagnosis and treatment may prevent admission
•  Multidisciplinary care may assist home management
•    Inhaled bronchodilators are effective treatments for acute 
exacerbations
Abbreviations:  COPD,  chronic  obstructive  pulmonary  disease;  FEV1,  forced 
expiratory volume in one second; PaO2, partial pressure of oxygen in the blood.
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Other results from Ta and George’s study22 included:
•	 medications not supported by the COPD-X guidelines – 
systematic steroids (24%) and prophylactic antibiotics 
(7%) – continued to be used long-term;
•	 44.4% had started a pulmonary rehabilitation program, 
with 20% of participants completing a program;
•	 24.4% had received medical instructions regarding the 
management of exacerbations; and
•	 48.9% reported good adherence in taking all of their 
COPD medications (mean 3.4).
ALF has also estimated that only 1% of patients with 
COPD who can benefit from PR have access to such 
programs.23 An ALF-commissioned survey of PR coordina-
tors indicated that the three main barriers to the operation of 
PR programs were patient transport, patient drop-out, and 
ongoing funding.24 A lack of awareness of PR programs by 
primary care providers was nominated as the most common 
barrier to access by those patients not currently using the 
programs that would benefit from them.
Part B: Current stakeholder 
perceptions about needed 
developments in COPD services 
and programs
The aim of Part B is to better understand ideas and insights 
about improving the prevention and care of COPD in 
Australia, both among people with the disease and their 
families, as well as relevant health professionals. These 
included:
•	 People with COPD and their caregivers attending patient 
support groups in Victoria;
•	 Coordinators of all PR groups in Victoria; and
•	 ALF, the peak body in Australia for relevant health care 
professionals with interest in pulmonary diseases, as 
well as people with these diseases and their families. A 
principal focus of ALF is people with COPD and their 
families.
People with COPD and their caregivers
Methods
Submissions on problems and proposed solutions concerning 
COPD were sought from all 31 patient support groups in 
Victoria through the ALF newsletter. Questions were in two 
parts: first, how the government could improve awareness, 
prevention, detection, and treatment of COPD, and second, 
individual experiences of barriers to managing COPD and 
Table 2 Conformity of clinical practice with the COPD-X Plan
Matheson et al* 
(conducted  
2000)
Ta and George* 
(conducted  
2008)
Diagnosis of COPD  
provided by doctor
10% 87%
Respiratory tests performed 13% 71%
Specialist seen 15% 31%
Influenza vaccination 59% 87%
Pneumococcal vaccination 41% 69%
Oxygen therapy 3% 13%
Continued to smoke 15% 24%
Notes:  *Results  should  be  interpreted  carefully  given  differences  in  patient 
populations and some differences in the wording of questions.
Abbreviation: COPD, chronic obstructive pulmonary disease.
Conformity of clinical practice  
in Australia to the COPD-X Plan
It is possible to some extent to judge how far clinical prac-
tice in Australia conforms to the COPD-X Plan, largely as a 
result of two studies, even though they involve very different 
patient populations. The first of these is the 2000 study by 
Matheson et al, which was conducted three years before the 
publication of the first COPD-X Plan.8 The second is the 
2008 study by Ta and George, which was conducted five 
years after its publication.22 In contrast to Matheson et al’s 
large, population-based study,8 Ta and George’s study of 45 
COPD patients was drawn from one hospital in which the 
patients had been admitted with acute COPD exacerbations.22 
The group also had a large mean number of comorbidities 
(5.7), medications (10.4), and hospital admissions (3.1 in 
past 12 months).
The levels of conformity for parameters for both studies are 
set out in Table 2. With some caution due to differences in the 
two populations, these studies would seem to indicate increas-
ing conformity with the COPD-X plan. Substantial departures 
from evidence-based practice clearly remain, however.
Other results from Matheson et al’s study8 included:
•	 38.5% of the COPD-only group had seen a general prac-
titioner in the past 12 months;
•	 48.7% of the COPD-only group and 75% of the COPD/
asthma group had been prescribed inhaled medication for 
their breathing in the previous 12 months, while 18.0% and 
17.5%, respectively, had been prescribed oral medication 
for their breathing in the previous 12 months; and
•	 5.1% of the COPD-only group had been regularly using 
long-acting ß2 agonists during the past 12 months, while 
23.1% and 30.0%, respectively, had been regularly using 
inhaled steroids during the past 12 months.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
361
Signs of progress in the Australian post-2000 COPD experienceInternational Journal of COPD 2012:7
possible solutions. Twenty-one submissions were received: 
four on behalf of a particular patient support group, and 
17 from individuals within a patient support group. This 
submission-based approach was preferred to the more usual 
survey method (whether by questionnaire or interview), as it 
aimed to collect opinions of informants with opinions about 
future service development, rather than typical sufferers of 
COPD. The main points of these submissions, together with 
some direct quotes of support group members making sub-
missions, are set out below.
Results
A number of submissions included the comment that, while 
public awareness of asthma had increased as a result of mass 
media campaigns, public awareness of COPD remained very 
low. People believed that TV or radio awareness campaigns 
were the most effective ways of raising awareness, as these 
media communicate with a wide audience. Raising public 
awareness should include the meaning of the abbreviation 
COPD as, unlike asthma, it is not commonly understood.
A number of respondents commented that antismok-
ing campaigns should be targeted at specific groups, such 
as older people or teenagers. Below are two representative 
comments:
Back to the public campaign. Show the difference between 
a healthy 65-year-old exercising, golf, tennis, swimming, 
cycling compared to a COPD sufferer … hardly able to walk 
to the letter box, or leaning up against the shop window to 
try to get their breath.
Have more people of different age brackets appearing 
on the TV saying how they managed to quit.
A number of comments indicated that attitudes toward 
the disease needed to improve. Existing attitudes led to the 
disease being hidden, meaning that some people try to suf-
fer in silence:
… because of the lack of knowledge and understanding, the 
person with COPD tries to cover up and not let on … Most 
of the [people with COPD] I have met try to battle along on 
their own keeping quiet about their real condition.
A number of comments addressed the need for earlier 
detection of the disease. This required greater awareness by 
doctors and other health professionals, and highlights the 
need to investigate symptoms of shortness of breath and 
persistent cough by using lung function tests.
With regard to the treatment of COPD, some com-
ments pointed to the importance of reduced costs for 
medications and more information about the use of 
portable oxygen and concentrators, both for patients and 
for general practitioners. They regarded mobility aids 
such as scooters, walking frames, and walking sticks 
as vital for this group of clients, as “Lack of mobility 
as the disease progresses is a huge barrier to managing   
COPD.”
Pulmonary rehabilitation coordinators
Methods
Questionnaires were sent via email and mail to all 53 
PR program coordinators in Victoria. The questionnaire 
included a list of 19 interventions proposed to improve 
the awareness, prevention, or treatment of the disease (see 
Table 1). These interventions were identified by reviewing 
the research literature on COPD. Coordinators were invited 
to rank these interventions in a priority order (highest = 1; 
lowest = 6), and to provide additional comments in support 
of their rankings. Twenty-seven (50%) of the PR coordina-
tors responded.
Results
The mean levels for the respondents’ rankings are set out in 
Table 3. The priorities of the PR coordinators, perhaps not 
unexpectedly, related to PR programs. They rated increased 
numbers and support for PR programs as the highest priority, 
and the investigation of reasons for low PR program use as 
their fifth-highest priority.
I think it is vital that these programs are promoted and 
money is given to them and they are not the responsibility 
of the health services, as there are always budget restric-
tions on health services and you can’t get new equipment 
when it is needed.
The second-highest priority was more awareness cam-
paigns aimed at the community and targeted at geographic 
locations where COPD was likely to present particular 
problems.
The next two highest priorities related to general 
practitioners – specifically the better use of spirom-
etry and smoking cessation guidelines and awareness 
campaigns: “GPs need to be more aware of these pro-
grams and their benefits and thus referring to appropriate   
groups.”
The next two highest priorities related to government – 
first, to developing a government service framework for 
COPD to assist in the referral process, and second, to 
increasing support for ALF and its advocacy and awareness 
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activities. The next highest priority related to the need to 
improve other health professionals’ attitudes toward patients 
with COPD.
I work in both an acute setting (ED) and chronic illness 
programme … and am appalled by the apparent lack of 
awareness or concern of many of my fellow health profes-
sionals in regards to the severity of the problems associated 
with COPD. Before we can inform the general public the 
health profession needs to be targeted with some heavy duty 
awareness campaigns and education.
Along with other stakeholders, PR coordinators com-
mented that a multifaceted approach was needed to address 
current shortcomings.
Peak bodies
Representatives of ALF were contacted regarding priori-
ties for interventions to promote the prevention and man-
agement of COPD. Some other relevant bodies, such as the 
Australian Asthma and Respiratory Educators Association, 
were also contacted.
ALF is the peak body for COPD in Australia. Its long-
term COPD strategy includes all three levels of prevention, as 
well as disease management.16 Some of its goals include:
•	 Primary prevention of smoking;
•	 Improving rates of smoking cessation;
•	 Early detection of airflow limitation in smokers before 
disablement;
•	 Improved management of stable diseases; and
Table 3 Priority order among 19 potential interventions for PR coordinators (N = 26)
Intervention strategy Priority order Mean rank 
(1 = high; 6 = low)
Increased numbers of pulmonary rehab programs and increased  
support for existing pulmonary rehabilitation programs
1st 3.62
Target awareness campaigns in key geographical areas with  
high rates for of COPD, low rates of SES
2nd 4.81
Encourage use of spirometry in screening by general  
practitioners
Equal 3rd 5.00
Reinforce use of smoking cessation guidelines and awareness  
campaigns by general practitioners
Equal 3rd 5.00
Develop a government service framework for COPD Equal 4th 5.15
Increase support for Australian Lung Foundation advocacy  
and awareness activities
Equal 4th 5.15
Investigate reasons for low use of pulmonary rehabilitation programs;  
identification of ideal ratio of programs to population
5th 5.27
Intervene to improve health professionals’ attitudes toward  
patients with COPD
6th 5.31
Better information on prevalence of COPD at a regional  
or local levels
7th 5.50
Increase numbers and support for patient-support groups  
for those with COPD
8th 6.12
Routine referral of smokers to quitlines by general practitioners 9th 6.15
Target campaign to improve awareness of key at at-risk groups  
such as Asian or Middle Eastern men
10th 6.19
Identify key industries and groups of workers with high-risk  
occupational exposure to dust and fumes
11th 6.27
Increase awareness of dietary and weight risk factors for the  
general public, those at risk, and those with COPD
Equal 12th 6.31
Monitor air pollution levels and raise awareness of air pollution  
risk to lung function
Equal 12th 6.31
Increase advocacy and awareness activities of existing patient  
support groups
13th 6.35
Routine administration of influenza vaccinations  
for smokers and those with COPD
14th 6.42
Increased awareness of genetic susceptibility in families  
with COPD history
15th 6.58
Increased awareness and promotion of World COPD Day  
by local governments, primary care partnerships,
16th 6.73
Abbreviations: COPD, chronic obstructive pulmonary disease; PR, pulmonary rehabilitation; SES, socioeconomic status.
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•	 Preventing exacerbations in people with established 
COPD.
It has produced a case statement for communicating with 
different key groups. These are set out in Table 4.
In 2007, ALF stated that its priorities for action and 
government funding were to increase access to pulmonary 
rehabilitation, improve COPD diagnosis through enhanced 
access to spirometry testing, ensure equity of access to 
home oxygen, secure direct funding for epidemiological 
research, improve COPD diagnosis through increased 
community awareness, and increase funding to enhance 
self-management strategies for COPD patients.23 In 2009, 
ALF management, in response to our request to prioritize 
the 19 interventions considered by the PR coordinators (see 
above), nominated the following interventions in descending 
order of priority:
1.  Develop a government service framework for COPD;
2.  Target awareness campaigns in key geographical areas 
with high rates of COPD and low socioeconomic 
status;
3.  Investigate reasons for low use of PR programs and 
identify ideal ratios of programs to populations;
4.  Increase numbers of pulmonary rehab programs and 
secure increased support for existing PR programs;
5.  Encourage the use of spirometry in screening by general 
practitioners; and
6.  Intervene to improve health professionals’ attitudes 
toward patients with COPD.
Discussion
Trends in COPD mortality rates
A review of the research evidence makes it clear that mortal-
ity from COPD in men has been halved from 1980 to 2007, 
and that the prevalence of the disease has also considerably 
declined. This has been accompanied by a very large reduc-
tion in smoking rates in men and a lesser reduction in smok-
ing rates for women. These can be attributed in substantial 
part to the very active smoking cessation programs in all 
Australian states and territories from 2000 to 2010.
This trend in mortality appears inconsistent with the 
projection by Murray and Lopez from the Global Burden 
of Disease (GBD) study, which, using a risk factor model, 
predicted that COPD would become the third-leading cause 
of death by 2020.1 The application of another risk factor 
model to COPD in the Netherlands by Feenstra et al also 
concluded that there will be a 75% increase in disability-
adjusted life years lost between 1994 and 2015. This was 
deemed to be largely due to an aging in the population and 
past smoking behavior, with changes in smoking rates having 
only a small effect.25
In contrast, however, Lopez et al noted that the risk factor 
model used in the GBD study provided a relatively poor fit for 
the data. They used instead an extrapolation model, specifi-
cally a Bayesian age-period-cohort model.26 In conducting 
this analysis, they noted that deaths from COPD in males 
and younger females have declined in England and Wales 
in recent years (with the decline starting at different periods 
in different age groups), but have been increasing in older 
females. This UK trend is similar to the Australian trend 
described earlier.
The authors of the Lopez study tested the model by 
making short-term forward predictions for the period from 
1990 to 1999 using longer-term data and comparing these 
with routinely available mortality data for the same period. 
They obtained estimates of median totals for COPD deaths 
within 9% for male and 5% for female observed rates. 
Projections for 2000–2009 suggested a median fall in death 
rates for males of 24% by 2009 on a 1999 baseline and a cor-
responding 2% rise for females, albeit with wide confidence 
intervals associated with marked year-to-year fluctuations in 
rates. While the authors counsel caution in the ability of any 
models to make longer-term predictions, it is clear that they 
were implicitly drawing attention to limitations in the GBD 
model and its prediction that COPD mortality rates will rise 
to very high levels in the future.
Trends in COPD management
New local evidence-based guidelines based on the GOLD 
guidelines have also been published. Several governments 
and ALF have provided support for these guidelines, as well 
as support for self-management and coordinated care.
Table 4 A framework for communicating appropriate messages 
about  COPD  to  different  target  groups.  Copyright  ©  2001, 
Australian Lung Foundation. Reproduced with permission from 
lungnet.com.au  [website  on  the  Internet].  Australian  Lung 
Foundation.  2001.  Available  from:  http://www.lungnet.com.au/
home/default.htm. Accessed November 11, 2008.34
Target groups Message
People with COPD “Something can be done”
People unaware they have COPD “Take control now before  
it becomes a problem”
General public (candidates for COPD) “Smoking causes COPD”
Health professionals “Things have changed  
in COPD”
government “COPD is a major problem”
Abbreviation: COPD, chronic obstructive pulmonary disease.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
364
Dunt and DoyleInternational Journal of COPD 2012:7
It is difficult to precisely assess the contribution of 
these activities in increasing conformity with the COPD-X 
Plan. This is because the Matheson et al study, conducted 
before publication of the COPD-X Plan, and the Ta and 
George study, conducted after its publication, involve very 
different patient populations.8,22 Nevertheless, it is appar-
ent that, while some progress seems to have occurred, both 
studies report considerable departures from evidence-based 
practice. Ta and George believe, however, that there may 
have been some increase in influenza immunization rates 
across the relevant study period. This lack of obvious prog-
ress contrasts with the clear progress that has been made 
in the smoking-cessation area. A replication or extension 
of the Matheson et al study would enable judgments about 
changes in practices highlighted in the COPD-X Plan during 
the last five years.
Community and professional  
awareness of COPD
A common priority for patients, PR coordinators, and ALF 
was that there needed to be greater awareness of COPD in the 
Australian community generally and – more specifically – in 
the general practitioner and health professional communities. 
This, however, needed to be accompanied by a more positive 
orientation toward people with COPD. This was needed to 
overcome the stigma of what many saw as a self-inflicted 
disease. It is easy to imagine that this stigma can easily com-
pound professional attitudes of therapeutic nihilism toward 
the disease. Progress in reducing disease levels and smok-
ing rates gives convincing illustrations that this therapeutic 
nihilism is unjustified.
ALF sponsored a community awareness media campaign 
about COPD in Toowoomba, Queensland, in August 2007.27 
It included print, radio, and television advertisements and 
aimed to improve early detection. Printed leaflets and dis-
plays in general practitioner waiting rooms, pharmacies, 
community health centers, and other outlets were used 
to increase awareness. This occurred alongside radio and 
television and printed media campaigns being run in a con-
centrated time period over one month. Similar campaigns 
aimed at raising awareness in both Norway and the United 
States have reported success in raising awareness in COPD 
in their respective populations.28,29 A more recent campaign 
(Show Us Your Lungs, 2011) was instigated by ALF, but 
evaluation of the effectiveness of the campaign has yet to 
be published.30
Awareness campaigns are also needed to address 
stigmas, as well as low awareness. A modification of the 
message of the Global Lung Cancer Coalition (“No one 
deserves lung cancer”), to “No one deserves COPD” could 
be considered.31
Other priorities nominated by stakeholders included 
needed changes in general practice, such as earlier detec-
tion with spirometry in general practice, better smoking 
cessation programs, and an expanded (and cheaper) range 
of aids to support patients. A recent study by Abramson et al 
was unable, however, to demonstrate that thrice-monthly 
spirometry and regular medical reviews by general practi-
tioners were associated with any significant improvement 
in quality of life or other health outcomes for patients with 
asthma and/or COPD.32
Some nominated the need for the expansion of pulmo-
nary rehabilitation programs (alongside a study of the rea-
sons for their current low use). Some also spoke of the need 
for a program similar to the National Service Framework 
(renamed the National Clinical Strategy for COPD), which 
exists in the UK. This specified the minimum standards of 
treatment and care that people with COPD can expect in 
their locality, and aims to facilitate people having access 
to the same standard of care regardless of where they   
live.33
Limitations of the research
While this informant approach was adequate for the purposes 
of this study, additional expressions of opinion from a more 
representative group of COPD sufferers and health profes-
sionals would have provided further insight. The insights 
from Australian experience do not, of course, necessarily 
translate to other countries with different health systems. In 
addition, the study of PR coordinators and COPD patients in 
patient support groups was based in Victoria, and may not 
be representative of the views involving these groups across 
Australia.
Conclusion
A reduction in mortality rates and the prevalence of COPD, 
alongside reductions in smoking cessation rates, contrast 
with the more limited progress that has been made in the 
adoption of other aspects of evidence-based practice for 
COPD in Australia. It provides further evidence that nihilism 
in relation to COPD is not justified. This could form the 
focus for media campaigns aimed at this and other aspects 
of community awareness and attitudes in relation to COPD. 
The recent passage through the Australian Parliament of 
required plain packaging of cigarettes is further illustration 
that progress can be expected.
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